Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

R
Rafat Abonour, MD

Primary Investigator

Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)
Recruiting
40 years - 75 years
All
Phase N/A
1 Location

Brief description of study

We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.  
 
 
Your participation may help researchers find new ways to prevent and treat blood cancer.
 
 

Detailed description of study

 
Please take our survey to see if you qualify: PROMISE Eligibility Questionnaire  
 
 

This study aims to find new ways to prevent and treat blood cancer.

 
Your participation may help prevent multiple myeloma in future generations. 
 
 

For more information, please visit the PROMISE study website: https://www.enroll.promisestudy.org/

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: All
  • Age: 40 years - 75 years
  • Gender: All

Inclusion criteria
  • People who may have higher risks, but have not been diagnosed with multiple myeloma, another blood cancer, or related conditions
 

Updated on 06 Mar 2025. Study ID: 2005821833

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center